The World Health Organization warns of critical shortages in GLP-1 weight loss drugs like Wegovy, with fewer than 10% who need them able to access treatment. Urgent action is needed to prevent obesity rates from soaring.
The World Health Organization warns fewer than 10% who need obesity drugs like Wegovy can access them. With costs soaring and supply limited, urgent action is needed to prevent a global health crisis.
Savile Row tailors face a new challenge as clients on weight loss drugs like Ozempic rapidly change shape, requiring entire suits to be remade. Discover the impact on bespoke tailoring.
Exclusive: Dozens of deaths in Britain have been linked to blockbuster weight loss injections like Ozempic and Mounjaro. Experts sound the alarm over inappropriate use.
WeightWatchers announces plans to sell Novo Nordisk's Wegovy in pill form, a strategic move following its bankruptcy. Discover how this impacts the competitive weight-loss drug market.
Donald Trump launches astonishing attack on revolutionary weight-loss injections like Wegovy and Ozempic, branding them the 'fat shot' while claiming natural methods are superior. The former president's controversial health comments spark medical debate.
Former President Donald Trump proposes dramatic government intervention to cut costs of blockbuster drugs like Ozempic and Wegovy, challenging pharmaceutical giants and reshaping US healthcare policy.
Former President Donald Trump vows to dramatically reduce prices of GLP-1 medications including Ozempic and Wegovy if re-elected, targeting pharmaceutical giants in latest healthcare pledge.
Australian drivers are experiencing unprecedented waiting times for essential car servicing, with some facing six-month delays as the nation's mechanic shortage reaches crisis levels.
The pharmaceutical weight loss market heats up as Novo Nordisk's blockbuster drugs Wegovy and Ozempic confront serious competition from Eli Lilly's Mounjaro, reshaping diabetes and obesity treatment landscapes.
Danish pharmaceutical giant Novo Nordisk cuts sales and profit forecasts for second time amid intensifying competition in weight-loss drug market.
Explosive revelations emerge about Donald Trump's private stance on revolutionary weight loss drugs while new research highlights their massive economic potential.
American retailers including Giant Eagle and Sheetz are implementing creative solutions as a nationwide coin shortage forces changes to cash transactions.
New CDC data reveals American obesity rates have hit unprecedented levels, while revolutionary GLP-1 medications like Wegovy and Zepbound show promising results in combating the epidemic.
Stanford psychologist reveals how weight-loss drugs like Wegovy create profound mental changes that could revolutionise obesity treatment beyond mere physical transformation.
As slimming injections surge in popularity, fitness centres report booming business from users fighting to preserve muscle mass while shedding pounds
Groundbreaking research shows popular weight loss medications like Wegovy and Ozempic dramatically reduce cardiovascular events, offering dual protection for patients.
University College London researchers call for expanding Wegovy access after revealing compelling new evidence that could change NHS obesity treatment guidelines.
Groundbreaking research shows popular weight loss injections like Wegovy and Ozempic significantly reduce cardiovascular risks alongside promoting weight loss, offering new hope for millions.
Groundbreaking research reveals popular weight loss injections Wegovy and Ozempic significantly reduce heart attack and stroke risks, offering dual benefits for millions struggling with obesity.
Danish pharmaceutical giant Novo Nordisk faces major leadership shakeup as chairman and six board members step down following unprecedented growth of weight-loss drug Wegovy.
Groundbreaking obesity medication Wegovy gains Medicaid coverage across multiple American states, marking a significant shift in healthcare policy for weight management treatments.
Britain faces a sweet crisis as Penguin bars vanish from supermarket shelves following McVitie's decision to pause production, sparking nationwide disappointment and frantic searches.
High street pharmacy chain Boots has suspended its popular 'fat jab' weight loss injection service following overwhelming demand and supply shortages, leaving thousands of customers seeking alternatives.
Groundbreaking research reveals popular weight-loss drugs Ozempic and Wegovy are causing dangerous stomach complications during medical scans, prompting urgent NHS warnings.
Groundbreaking research reveals GLP-1 medications prescribed for weight management are showing unexpected benefits in reducing alcohol consumption among users, with some reporting complete loss of interest in drinking.
Groundbreaking weight loss injections Wegovy and Mounjaro are transforming obesity treatment in the UK, offering new hope for thousands struggling with weight management through both NHS and private healthcare providers.
Groundbreaking research shows obesity injections like Mounjaro and Wegovy deliver unprecedented weight loss results, potentially transforming NHS treatment approaches and offering new hope for millions struggling with weight management.
Exclusive: The Department of Health reveals ongoing medicine supply issues affecting NHS patients across Britain, with officials working urgently to resolve critical shortages.
Groundbreaking research reveals nearly 5% of UK adults are turning to revolutionary weight loss injections like Wegovy and Mounjaro, with overwhelming majority paying privately amid NHS supply constraints.